Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/11/e001731corr2.full
_version_ 1797426519748902912
collection DOAJ
first_indexed 2024-03-09T08:31:25Z
format Article
id doaj.art-0eca4aca1de7489d8e986059f1023d82
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-09T08:31:25Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-0eca4aca1de7489d8e986059f1023d822023-12-02T19:30:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-01111110.1136/jitc-2020-001731corr2Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomeshttps://jitc.bmj.com/content/11/11/e001731corr2.full
spellingShingle Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
Journal for ImmunoTherapy of Cancer
title Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
title_full Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
title_fullStr Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
title_full_unstemmed Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
title_short Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
title_sort correction steroid refractory pd l 1 pneumonitis incidence clinical features treatment and outcomes
url https://jitc.bmj.com/content/11/11/e001731corr2.full